Surgery and chemotherapy together improved survival in GIST patients with liver metastases, increasing median cancer-specific ...

Dr. William A. Hall sat down with CURE for a live interview at the 2026 ASCO Gastrointestinal Cancers Symposium to discuss ...

To make cancer care smoother and more effective, the Alliance for Clinical Trials in Oncology has introduced a new clinical ...

Better treatment options have improved survival rates in the U.S., according to a report from the American Cancer Society.

GLP-1 drugs are 36% more effective than aspirin in reducing colorectal cancer risk, with fewer side effects like acute kidney ...

To make cancer care smoother and more effective, the Alliance for Clinical Trials in Oncology has introduced a new clinical ...

The overall response rate (ORR) is 35%; this increases to 42% when including unconfirmed responses Narmafotinib continues to be well tolerated by patients with the adverse effect profile of the ...

Regular walking during recovery may reduce cancer-related fatigue and improve long-term well-being for patients with ...

BullFrog AI's bfLEAP platform identified biomarkers linked to improved survival in pancreatic adenocarcinoma patients treated ...

New subgroup analysis shows consistent, clinically meaningful pain reduction observed from Stage 2 through Stage 4 disease, ...

First-line zanidatamab plus chemotherapy leads to ‘practice-changing’ PFS and overall survival gains in a phase 3 study of ...

Encouraging anti-tumour activity seen across all dose levels and in various tumour indicationsClinical benefit rate of 80% ...